BREAKING
Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 seconds ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 6 minutes ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 hour ago Abbott reports positive results from study on its atrial fibrillation therapies 2 hours ago Atmus Welcomes Heath Sharp to Board of Directors 4 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Tech Giants Report Record Q4 Earnings, Beat Wall Street Estimates 1 week ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 seconds ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 6 minutes ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 hour ago Abbott reports positive results from study on its atrial fibrillation therapies 2 hours ago Atmus Welcomes Heath Sharp to Board of Directors 4 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Tech Giants Report Record Q4 Earnings, Beat Wall Street Estimates 1 week ago
ADVERTISEMENT

TRxADE Health Inc (MEDS) Q3 2022 Earnings Call Transcript

TRxADE Health Inc (NASDAQ:MEDS) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Janet Huffman — Chief Financial Officer Suren Ajjarapu — Founder, Chairman and Chief Executive Officer…

TRxADE HEALTH, Inc. (MEDS) Q4 2021 Earnings Call Transcript

TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q4 2021 earnings call dated Mar. 28, 2022 Corporate Participants: Howard Doss — Chief Financial Officer Suren Ajjarapu — Chief Executive Officer Analysts: Allen Klee — Maxim…